Plasma soluble interleukin-2 receptor levels in patients with idiopathic thrombocytopenic purpura

American Journal of Hematology

Volumn 57, Issue 2, 1998, Pages 119-123

  Erduran, Erol ^a   Asian, Yakup ^a   Aliyazicioǧlu, Yüksel ^a   Mocan, Hilal ^a   Gedik, Yusuf ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

HDMP therapy; Idiopathic thrombocytopenic purpura; Soluble interleukin 2 receptor

Indexed keywords

CYTOKINE RECEPTOR; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE; THROMBOCYTE ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG EFFICACY; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LYMPHOCYTE ACTIVATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTERLEUKIN-2; MALE; METHYLPREDNISOLONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECEPTORS, INTERLEUKIN-2;

EID: 0031930748     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199802)57:2<119::AID-AJH5>3.0.CO;2-Z     Document Type: Article

References (24)

1. Smith KA: Interleukin-2: Inception, impact and implications. Science 240:1169, 1988.
2. Centrell DA, Smith G, Nelson DL: The interleukin-2 T-cell system: A new cell growth model. Science 224:1312, 1984.
3. Rubin LA, Jay G, Nelson DL: The released interleukin-2 receptor binds interleukin-2 efficiently. J Immunol 137:3841, 1985.
4. Balasubramanian S, Chernov-Rogan T, Davis AM, Whitehorn E, Tate E, Bell MP, Zurawski G, Barret RW: Ligand binding kinetics of IL-2 and IL-5 to heteromers formed by extracellular domains of the three IL-2 receptor subunits. Int Immunol 7:1839, 1995.
5. Ward MM, Dooley MA, Christenson VD, Pitesky DS: The relationship between soluble interleukin-2 receptor levels and anti-double stranded DNA antibody levels in patients with systemic lupus erythematosus. J Rheumatol 18:235, 1991.
6. Muller K, Pedersen FK, Wiik A, Bendtzen K: Lymophokines and soluble IL-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations. Rheumatol Int 12:89, 1992.
7. Greenberg SJ, Marcon L, Hurwitz BJ, Waldmann TA, Nelson DL: Elevated levels of soluble IL-2 receptors in multiple sclerosis (letter). N Engl J Med 319:1019, 1988.
8. Semezato G, Foa R, Agostin FC, Zombello R, Trentin L, Vinante F, Benedetti F, Chilosi M, Pizzalo G: High serum levels of soluble IL-2 receptors in patients with B cell chronic lymphatic leukemia. Blood 70:396, 1987.
9. Richard J, Mick R, Latta JM, Daly K, Ratain MJ, Wardiman JW, Colomb HM: Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood 74:1052, 1990.
10. Cimino G, Amadori S, Cava MC, Mondelli F: Serum interleukin-2, soluble interleukin-2 receptor and tumor necrosis factor levels are significantly increased in acute myeloid leukemia patients. Leukemia 5:32, 1991.
11. Jen C, Wang JC, Wang A: Plasma soluble interleukin-2 receptor in patients with primary myelofibrosis. Br J Haematol 86:380, 1994.
12. Prin L, Plumas J, Gruart V, Loiseau S, Aldebert D, Ameisen JC, Vermersch A, Fenaux P, Bletry O, Capron M: Elevated serum levels of soluble interleukin-2 receptor: A marker of disease activity in the hypereosinophilic syndrome. Blood 78:2626, 1991.
13. Zwierzina H, Herold M, Schollenberger S, Geissler D, Schmalzl F: Detection of soluble interleukin receptor in the serum of patients with myelodysplastic syndromes: Induction under therapy with GM-CSF. Br J Haematol 79:438, 1991.
14. Cause A, Roschansky V, Tschiersch A, Smith K, Hasenclever D, Schmits R, Diehl V, Pfreundschuhm R: Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma. Ann Oncol 2:43, 1991.
15. Ware RE, Howard TA: Elevated numbers of gamma-delta (gamma-delta +) T lymphocytes in children with immune thrombocytopenic purpura. J Clin Immunol 14:237, 1994.
16. Adachi Y, Inaba M, Negata N, Kabayashi Y, Ikeshara S: Functional analysis of B cell in (NZW×BXSB) F, mice. Autoimmunity 15:99, 1993.
17. Hedge UM: Platelet antibodies in immune thrombocytopenia. Blood Rev 6:34, 1992.
18. Ozsoylu Ş. High-dose intravenous methylprednisolone (HIVMP) in haematologic disorders. Haematol Rev 4:197, 1990.
19. Ware RE. Howard TA: Phenotypic and clonal analysis of T lympho- cytes in childhood immune thrombocytopenic purpura. Blood 82:2137, 1993.
20. Koyanagi H, Kishida K, Shimamura K, Kurokawa M, Deguchi T, Shimoda Y. Immunological study of childhood acute ITP at onset. Pediatr Hematol Oncol 9:11, 1992.
21. Mizutami H, Furubayashi T, Kashiwagi H, Honda S, Take H, Kurata Y, Yonezawa T, Tarui S: B cell expressing CD5 antigens are markedly increased in peripheral blood and spleen lymphocytes from patients with immune thrombocytopenic purpura. Br J Haematol 78:474, 1991.
22. Symous JA, Wood NC, Di Giovine FS, Duff GW: Soluble IL-2 re- ceptors in rheumatoid arthritis: Correlation with disease activity and IL-1 and IL-2 inhibition. J Immunol 141:2612, 1988.
23. Mariotti S, Caturegli P, Babesino G, Del Prete GF, Chiovato L, Pinchera A: Circulating soluble interleukin-2 receptor concentration is increased in both immunogenic and nonimmunogenic hyperthyroidism. J Endocrinol Invest 14:777, 1991.
24. Nyabenda J, Turneer M, Waelbroeck A, Duvivier A, Toppet M: Interleukin-2 and soluble interleukin-2 receptor levels in children with acute pulmonary tuberculosis and atypical mycobacterial adenitis. Eur Cytokine Netw 4:43, 1993.